Singapore markets open in 4 minutes

Biora Therapeutics, Inc. (PROG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8845-0.0318 (-3.47%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 137.23M
Enterprise value 175.24M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)57.45
Price/book (mrq)N/A
Enterprise value/revenue 147.63
Enterprise value/EBITDA -1.67

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-66.36%
S&P500 52-week change 3-2.90%
52-week high 36.2000
52-week low 30.6301
50-day moving average 31.1002
200-day moving average 31.7983

Share statistics

Avg vol (3-month) 36.63M
Avg vol (10-day) 33.3M
Shares outstanding 5184.2M
Implied shares outstanding 6N/A
Float 8139.45M
% held by insiders 19.16%
% held by institutions 129.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 0.00%
Operating margin (ttm)-9,449.64%

Management effectiveness

Return on assets (ttm)-55.95%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.25M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)310.40%
Gross profit (ttm)1.25M
EBITDA -116.4M
Net income avi to common (ttm)-178.52M
Diluted EPS (ttm)-2.5730
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.4M
Total cash per share (mrq)0.48
Total debt (mrq)126.89M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.60
Book value per share (mrq)-0.47

Cash flow statement

Operating cash flow (ttm)-167.49M
Levered free cash flow (ttm)-52.35M